Stein, A., Kretzschmar, A., Behringer, D., Wolff, T., Zimber, J., Hegewisch-Becker, S., . . . Arnold, D. (2013). Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: Final results from phase II AIO KRK 0105 trial. BioMed Central.
Chicago ZitierstilStein, Alexander, et al. Capecitabine and Bevacizumab for Non-resectable Metastatic Colorectal Cancer Patients: Final Results From Phase II AIO KRK 0105 Trial. BioMed Central, 2013.
MLA ZitierstilStein, Alexander, et al. Capecitabine and Bevacizumab for Non-resectable Metastatic Colorectal Cancer Patients: Final Results From Phase II AIO KRK 0105 Trial. BioMed Central, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.